BVS Bioventus Global Net earnings per share (EPS TTM)

Bioventus Inc. (BVS) - corporate logo

Geopolitical risks and biomaterial logistics disruptions are limiting the sales markets for Bioventus Inc. (BVS), a trend confirmed by the EPS figures over the last 12 months, where the 0.81 mark reflects the latest data. R&D investments and a strong engineering team sustain the business's stability. Furthermore, a successful debt restructuring has restored the professional community's confidence in the quality of the company's orthopedic implants.

Bioventus Inc. (BVS) - Earnings per share for the trailing year from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Bioventus Corp (BVS)

- stock price and consensus target price:
Stock Price Bioventus Global|BVS - Average Forecast Price
- market capitalization data:
Market Capitalization Bioventus|BVS - Business Value
- business book valuation details:
Accounting Value per Share Bioventus|BVS - Accounting Value of Company|Market Value to Book Value Ratio bioventus.com|BVS - Cumulative Company Assets
- debt burden and liquidity indicators:
Total Debt to Capital Bioventus Inc.|BVS - Long-Term Liabilities to Capital|Short-Term Debt to Capital Bioventus|BVS - Company Aggregate Debt|Debts to Book Capitalization Bioventus|BVS - Long-Term Debt Volume|Company Short-Term Debts Bioventus|Quick Ratio bioventus.com
- earnings and valuation multiples indicators:
BVS - Net Profit|Expected Profit Bioventus Inc.|BVS - Price to Earnings Ratio|Projected Price to Earnings Bioventus Corp|BVS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Bioventus Inc.|BVS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Bioventus|BVS - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months bioventus.com|BVS - Earnings growth in current year|Earnings growth forecast for next year Bioventus Inc.
- issuer revenue and sales details:
BVS - Company Gross Revenue|Company Projected Revenue Bioventus Inc.|BVS - Price-to-Sales Ratio|Price-to-Projected Revenue Ratio Bioventus Global
Fundamental valuation:Bioventus Inc (BVS)
Manufactured products of Bioventus Inc

The scaling of Bioventus Inc. (BVS) across US clinics and the patent protection of Exogen systems directly impact cash flow generation efficiency, as reflected in the rolling earnings per share history. This indicator measures the net income attributable to a single share per year, allowing investors to assess the real return on capital regardless of issuance factors and determine the long-term sustainability of the business.

Competitors of Bioventus Inc.

Boston Scientific Corporation Inc. - Net earnings per share (EPS TTM)|EW (Edwards Lifesciences Corp) - Earnings per share for the last 12 months|RMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months OmniPod (PODD)|Net earnings per share for the last 12 months ZBH|COO: Earnings per share for the trailing year|Net earnings per share for the last 12 months ALGN (Align Technology)|GMED (Globus Medical Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months TransMedics Group TMDX|ATEC - Net earnings per share for the last 12 months|CryoLife - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Enovis Corporation|IART: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months ESTA|BBNX (iLet Bionic Pancreas) - Net earnings per share (EPS TTM)|Iradimed (IRMD) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) EMBC|Net earnings per share for the last 12 months Tandem Diabetes Care TNDM|Net earnings per share (EPS TTM) AXGN (axogeninc.com)|Net earnings per share (EPS TTM) SI-BONE Inc SIBN|OFIX - Earnings per share for the last twelve months|KIDS: Earnings per share for the last twelve months|TMCI (Treace Medical Concepts) - Net earnings per share for the last 12 months|Strata Critical Medical Inc - Earnings per share for the trailing year|CARL (Carlsmed Medical) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months RxSight Inc RXST|Earnings per share for the last twelve months ClearPoint Neuro (CLPT)|Stereotaxis, Inc. (STXS) - Net earnings per share for the trailing year|Neuronetics, Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Sight Sciences, Inc. SGHT|Orchestra BioMed Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Anika Therapeutics, Inc. ANIK|InspireMD (NSPR) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZJYL (Jin Medical International Ltd)|Earnings per share for the last twelve months vivani.com|Net earnings per share for the last 12 months Xtant Medical Holdings (XTNT)|Net earnings per share (EPS TTM) NMTC|MODD - Net earnings per one share for the last twelve months|Myomo - Net earnings per share for the last 12 months|COCH: Earnings per share for the last 12 months|VVOS: Net earnings per share for the last 12 months|enVVeno Medical - Earnings per share for the last four quarters|Sintx Technologies (SINT) - Earnings per share for the last twelve months|TNON: Earnings per share for the last four quarters|LFWD (rewalk.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Autonomix Medical|Earnings per share for the last twelve months INVO Bioscience (IVF)|Bone Biologics - Earnings per share for the last 12 months|Earnings per share for the last twelve months Axonics Modulation Technologies AXNX|BIOLASE - Earnings per share for the last twelve months|DYNT: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Paragon 28|INVO: Net earnings per share (EPS TTM)